title: Comment on "Fingolimod effects on left ventricular function in multiple sclerosis" Mult Scler 2015.
authors.affiliation: Novartis Pharma AG, Switzerland rajesh.bakshi@novartis.com.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Bakshi
authors.affiliation: Novartis Pharma AG, Switzerland.
authors.forename: Dieter A
authors.initials: DA
authors.lastname: Häring
mesh_terms: D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy; D011409:Propylene Glycols; D013110:Sphingosine; D016277:Ventricular Function, Left
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine